pattismith
Senior Member
- Messages
- 3,988
These data demonstrate that reduced Cerebral Blood Flow in MS is mediated by Endothelin 1, which is likely released in the cerebral circulation from reactive astrocytes in plaques.
According to this 2019 study, Sulfisoxazole inhibits the secretion of small extracellular vesicles (exosomes) by targeting the endothelin receptor A. (Sulfisoxazole is a non selective antagonist for endothelin receptors)
This other recent study indicates a possible role of exosomes in Systemic Sclerosis (an autoimmune disease) pathogenesis.
And Systemic Sclerosis was found to be associated with high anti Endothelin A receptor auto-antibodies. (These antibodies are in the Cell Trend panel for POTS).
These Ab are activator to these receptors...
So my question would be : could ETA inhibitors have a beneficial effect on CFS/ME (either by improving cerebral blood flow or by decreasing exosomes)?
I have high anti ETAR Ab, so I wish to try them, but I don't have access … Anyone ever try one?
According to this 2019 study, Sulfisoxazole inhibits the secretion of small extracellular vesicles (exosomes) by targeting the endothelin receptor A. (Sulfisoxazole is a non selective antagonist for endothelin receptors)
This other recent study indicates a possible role of exosomes in Systemic Sclerosis (an autoimmune disease) pathogenesis.
And Systemic Sclerosis was found to be associated with high anti Endothelin A receptor auto-antibodies. (These antibodies are in the Cell Trend panel for POTS).
These Ab are activator to these receptors...
So my question would be : could ETA inhibitors have a beneficial effect on CFS/ME (either by improving cerebral blood flow or by decreasing exosomes)?
I have high anti ETAR Ab, so I wish to try them, but I don't have access … Anyone ever try one?